Skip to content

13F-HR filed by Nextech Invest Ltd.

Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 11 holding rows worth $536,819,845.

Accession
0001104659-24-023793
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 11 entries on the cover page, a total value of $536,819,845 stated on the cover page (in dollars after the unit check, H1), rows summing to $536,819,845 with VALUE read as dollars as filed, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock6,296,740$180,590,503dollars as filed
ARVINAS INC04335A105COM1,695,645$69,792,748dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock2,642,502$61,173,921dollars as filed
TANGO THERAPEUTICS INC87583X109COM5,533,980$54,786,402dollars as filed
AMBRX BIOPHARMA INC641871108COM3,129,300$44,561,232dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM4,285,714$39,428,569dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK2,518,582$34,882,361dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock1,346,409$14,823,963dollars as filed
Mersana Therapeutics Inc59045L106Common Stock5,978,327$13,869,719dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,221,145$12,443,468dollars as filed
ARS PHARMACEUTICALS INC82835W108COM1,910,029$10,466,959dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-023793this filing2024-02-14acceptance time not in the bulk data set